• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


Ionis Pharma's TRYNGOLZA Receives FDA Approval For Genetic Disorder Treatment

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 19, 2024 at 09:42: PM
via Ionis Pharmaceuticals Inc. (IONS) announced that the U.S. Food and Drug Administration approved TRYNGOLZA (olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare, genetic form of severe hypertriglyceridemia (sHTG) that can lead to potentially life-threatening acute pancreatitis.

article source
 






Top Bottom
Back
Quote